Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Simes

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Annals of Internal Medicine|May 16, 2001
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trialD Hunt, P Young, J Simes, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.
British Medical Journal (Clinical Research Ed.)|October 25, 1986
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancerR J Simes, M H Tattersall, A S Coates, et al.
Archives of Internal Medicine|November 14, 2000
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study InvestigatorsR A Stewart, K J Sharples, F M North, et al.
European Heart Journal|January 17, 2002
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling projectJ Simes, C D Furberg, E Braunwald, et al.
Optics Letters|September 15, 2009
Optically controlled reflection modulator using GaAs-AlGaAs n-i-p-i/multiple-quantum-well structuresK K Law, J Maserjian, R J Simes, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2009
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of biasC K Lee, S J Lord, M R Stockler, et al.
Lancet (London, England)|January 15, 2008
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, P M Kearney, L Blackwell, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?P M Ellis, P N Buttow, R J Simes, et al.
Applied Optics|June 10, 2010
Fabry-Perot multiple-quantum well index modulatorR J Simes, R H Yan, R Geels, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Annals of Internal Medicine|May 16, 2001
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trialD Hunt, P Young, J Simes, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.
British Medical Journal (Clinical Research Ed.)|October 25, 1986
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancerR J Simes, M H Tattersall, A S Coates, et al.
Archives of Internal Medicine|November 14, 2000
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study InvestigatorsR A Stewart, K J Sharples, F M North, et al.
European Heart Journal|January 17, 2002
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling projectJ Simes, C D Furberg, E Braunwald, et al.
Optics Letters|September 15, 2009
Optically controlled reflection modulator using GaAs-AlGaAs n-i-p-i/multiple-quantum-well structuresK K Law, J Maserjian, R J Simes, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2009
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of biasC K Lee, S J Lord, M R Stockler, et al.
Lancet (London, England)|January 15, 2008
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, P M Kearney, L Blackwell, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?P M Ellis, P N Buttow, R J Simes, et al.
Applied Optics|June 10, 2010
Fabry-Perot multiple-quantum well index modulatorR J Simes, R H Yan, R Geels, et al.
Pageof 15